Evaluation of a new antidiuretic agent, desmopressin acetate (DDAVP).
Desmopressin acetate is a synthetic vasopressin analogue administered by the intranasal route. It is long-acting and well tolerated and may be the agent of choice for treating central diabetes insipidus.